BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2960211)

  • 21. Nicotine has no effect on the metabolism of exogenous arachidonic acid or prostaglandin E2 in isolated perfused rat and hamster lungs.
    Mänistö J; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):259-63. PubMed ID: 6440249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotrienes and other lipoxygenase metabolites of arachidonic acid: their role in edema, ischemia and demyelination of the central nervous system.
    Mayer M
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():181-6. PubMed ID: 2977480
    [No Abstract]   [Full Text] [Related]  

  • 23. Uterine prostaglandin production: arachidonic acid cascade, fact or fiction?
    Poyser NL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():443-7. PubMed ID: 6221628
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation.
    Esa AH; Paxman DG; Noga SJ; Hess AD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):80-6. PubMed ID: 3129847
    [No Abstract]   [Full Text] [Related]  

  • 25. The phospholipase C diglyceride lipase pathway contributes to arachidonic acid release and prostaglandin E2 formation in platelet-derived growth factor stimulated Swiss 3T3 cells.
    Habenicht AJ; Goerig M; Grulich J; Rothe D; Gronwald R; Schettler G; Kommerell B
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():37-9. PubMed ID: 3159224
    [No Abstract]   [Full Text] [Related]  

  • 26. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy.
    Bazan NG; Birkle DL; Tang W; Reddy TS
    Adv Neurol; 1986; 44():879-902. PubMed ID: 3010683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats.
    Erman A; Hassid A; Baer PG; Nasjletti A
    J Pharmacol Exp Ther; 1986 Oct; 239(1):296-301. PubMed ID: 3093672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of GABA-energic system in the central nervous system in clinical psychologic medicine].
    Ciu Z; Gao BL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):249-51. PubMed ID: 2253516
    [No Abstract]   [Full Text] [Related]  

  • 29. Central nervous system receptors in neuropsychiatric disorders.
    Kato G; Ban T
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):207-22. PubMed ID: 6216501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a role of the arachidonic acid cascade in affective disorders: a review.
    Sublette ME; Russ MJ; Smith GS
    Bipolar Disord; 2004 Apr; 6(2):95-105. PubMed ID: 15005747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butaperazine pharmacokinetics in tardive dyskinesia.
    Wolf ME; Javaid JI; Mosnaim AD; Davis JM
    Biopharm Drug Dispos; 1985; 6(2):223-7. PubMed ID: 2860932
    [No Abstract]   [Full Text] [Related]  

  • 32. Arachidonic acid metabolism in the nervous system. Physiological and pathological significance.
    Ann N Y Acad Sci; 1989; 559():1-504. PubMed ID: 2772606
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostaglandins and schizophrenia.
    Horrobin D
    Lancet; 1980 Mar; 1(8170):706-7. PubMed ID: 6103110
    [No Abstract]   [Full Text] [Related]  

  • 34. Preventing aggressive/violent behavior: a role for biomarkers?
    Pinna M; Manchia M
    Biomark Med; 2017 Sep; 11(9):701-704. PubMed ID: 30669857
    [No Abstract]   [Full Text] [Related]  

  • 35. The biochemistry of mental illness.
    Smith BH; Rosich-Pla A
    Psychosomatics; 1979 Apr; 20(4):278-9, 282-3. PubMed ID: 35811
    [No Abstract]   [Full Text] [Related]  

  • 36. Exploration of the central nervous system serotonin in humans.
    WOOLLEY DW; CAMPBELL NK
    Ann N Y Acad Sci; 1962 Jan; 96():108-17. PubMed ID: 14008292
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral adrenergic receptors in affective illness and schizophrenia.
    Pandey GN; Pandey SC; Davis JM
    Pharmacol Toxicol; 1990; 66 Suppl 3():13-36. PubMed ID: 2179928
    [No Abstract]   [Full Text] [Related]  

  • 38. Quinacrine effects on the central nervous system.
    Engel GL
    JAMA; 1966 Aug; 197(6):515. PubMed ID: 5952734
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Molecules and mental health.
    Br Med J; 1975 Feb; 1(5953):296. PubMed ID: 1111787
    [No Abstract]   [Full Text] [Related]  

  • 40. Peripheral thyroxine metabolism in patients with psychiatric and neurological diseases.
    REICHLIN S
    AMA Arch Gen Psychiatry; 1959 Oct; 1():434-40. PubMed ID: 14437062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.